Vicki Moore, PhD

Contributing Writer https://www.oncologynurseadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

General Oncology

Patterns of Gabapentinoid Use Over Time in Patients With Cancer

Vicki Moore, PhD

November 14, 2019

A cross-sectional survey examined Medical Expenditure Panel Survey data on prescriptions for gabapentinoid medications given for pain management in patients with cancer.

Lymphoma

Survival Outcomes Associated With Infusion Reactions With Rituximab in Diffuse Large B-Cell Lymphoma

Vicki Moore, PhD

November 12, 2019

A retrospective cohort analysis found that patients with DLBCL who experienced infusion reactions during treatment with rituximab had prolonged overall survival. In addition, progression-free survival was affected in subsets of patients with DLBCL.

Multiple Myeloma

VTE Thromboprophylaxis Essential When Treating Newly Diagnosed MM With Lenalidomide, Steroid-Based Therapy

Vicki Moore, PhD

October 31, 2019

Optimal thromboprophylaxis for VTE was found to be essential in patients with NDMM, especially those at high risk.

Younger cancer survivors may face ongoing quality of life issues.

Leukemia

Young Patients Report Improved Quality of Life After Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia

Vicki Moore, PhD

October 29, 2019

Using EQ-5D and PedsQL, researchers determined the long-term effect of tisagenlecleucel treatment on quality of life for pediatric and young patients with R/R B-cell ALL.

Chronic Myeloid Leukemia‎

Follow-Up Results of Low-Dose Dasatinib for Chronic-Phase Chronic Myeloid Leukemia

Vicki Moore, PhD

October 28, 2019

Patients received 50 mg dasatinib daily and demonstrated 2-year rates of overall and event-free survival of 100%.

Colorectal Cancer

Colorectal Liver Metastasis Linked to Chronic Hepatitis B Infection Status

Vicki Moore, PhD

October 17, 2019

A retrospective analysis of more than 7000 patients found a potential association between colorectal cancer, hepatic metastasis, and chronic HBV status.